3D liver microtissues compose of human primary hepatocytes and a mixture of human primary hepatocyte, liver endothelial cells and kupffer cells
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00311
- Awardee
-
Insphero, Inc. UEI FCCCVSMNHGJ6 Part of Insphero AG
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $34,277
Award facts
- Opportunity
-
- 3D Liver Microtissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer Cells Pre-Solicitation · 75N95023Q00181 · Posted Apr 3, 2023
- Contract value 100% obligated
- $34,276.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Brunswick, ME 04011, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$300 | |
| Original award | $34,577 |
About this award
This federal contract award, valued at $34,276.75, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for the delivery of 3D liver microtissues composed of human primary hepatocytes, liver endothelial cells, and Kupffer cells, which will be used by NIDA's 3D Tissue Bioprinting Laboratory to study viral infectivity, the effects of viral infection on liver function biomarkers, and the impact of antiviral compounds on viral infection. This award is not associated with a set-aside program and is a firm-fixed-price purchase order. The parent company of Insphero Inc. is Insphero AG, another foreign-owned, for-profit organization.
Quick answers
Who was awarded contract 75N95023P00311?
75N95023P00311 was awarded to Insphero, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 25, 2023.
How much is contract 75N95023P00311 worth?
The government has obligated $34,277 on 75N95023P00311.
Was contract 75N95023P00311 competed?
The extent of competition for 75N95023P00311 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award